Deep vein thrombosis of the upper extremity - A systematic review;Tiefe Venenthrombosen der oberen Extremität: Deep vein thrombosis of the upper extremity - a systematic review

Deutsches Arzteblatt International

Volumn 114, Issue 14, 2017, Pages 244-249

  Heil, Jan ^a   Miesbach, Wolfgang ^a   Vogl, Thomas ^a   Bechstein, Wolf O ^a   Reinisch, Alexander ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEEP VEIN THROMBOSIS; HUMAN; REVIEW; SYSTEMATIC REVIEW; UPPER LIMB; ARM; DIAGNOSTIC IMAGING; ECHOGRAPHY; INCIDENCE; LUNG EMBOLISM; MALE; VASCULARIZATION; VEIN THROMBOSIS;

ANTICOAGULANT AGENT;

ANTICOAGULANTS; ARM; HUMANS; INCIDENCE; MALE; PULMONARY EMBOLISM; ULTRASONOGRAPHY; VENOUS THROMBOSIS;

EID: 85017270040     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2017.0244     Document Type: Review

References (40)

1. Bleker SM, van Es N, Kleinjan A, et al.: Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis. JTH 2016; 14: 973-81.
2. Grant JD, Stevens SM, Woller SC, et al.: Diagnosis and management of upper extremity deep-vein thrombosis in adults. JTH 2012; 108: 1097-108.
3. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med 2009; 3: 123-30.
4. Cote LP, Greenberg S, Caprini JA, et al.: Comparisons between upper and lower extremity deep vein thrombosis: a review of the RIETE registry. Clin Appl Thromb Hemost 2016; pii: 1076029616663847 (epub ahead of print).
5. Encke A, Haas S, Kopp I: The prophylaxis of venous thromboembolism. Dtsch Arztebl Int 2016; 113: 532-8.
6. Sajid MS, Ahmed N, Desai M, Baker D, Hamilton G: Upper limb deep vein thrombosis: a literature review to streamline the protocol for management. Acta Haematol 2007; 118: 10-8.
7. Margey R, Schainfeld RM: Upper extremity deep vein thrombosis: the oft-forgotten cousin of venous thromboembolic disease. Curr Treat Options Cardiovasc Med 2011; 13: 146-58.
8. Lee JA, Zierler BK, Zierler RE: The risk factors and clinical outcomes of upper extremity deep vein thrombosis. Vasc Endovascular Surg 2012; 46: 139-44.
9. Stone RH, Bress AP, Nutescu EA, Shapiro NL: Upper-extremity deep-vein thrombosis: a retrospective cohort evaluation of thrombotic risk factors at a university teaching hospital antithrombosis clinic. Ann Pharmacother 2016; 50: 637-44.
10. Joffe HV, Goldhaber SZ: Upper-extremity deep vein thrombosis. Circulation 2002; 106: 1874-80.
11. Spencer FA, Emery C, Lessard D, Goldberg RJ, Worcester Venous Thrombo - embolism Study: Upper extremity deep vein thrombosis: a community-based perspective. Am J Med 2007; 120: 678-84.
12. Joffe HV, Kucher N, Tapson VF, Goldhaber SZ; Deep Vein Thrombosis (DVT) FREE Steering Committee: Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 2004; 110: 1605-11.
13. Baskin JL, Pui CH, Reiss U, et al.: Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 2009; 374: 159-69.
14. Grove JR, Pevec WC: Venous thrombosis related to peripherally inserted central catheters. JVIR 2000; 11: 837-40.
15. Evans RS, Sharp JH, Linford LH, et al.: Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest 2010; 138: 803-10.
16. Da Costa SS, Scalabrini Neto A, Costa R, Caldas JG, Martinelli Filho M: Incidence and risk factors of upper extremity deep vein lesions after permanent transvenous pacemaker implant: a 6-month follow-up prospective study. Pacing Clin Electrophysio 2002; 25: 1301-6.
17. Blom JW, Doggen CJ, Osanto S, Rosendaal FR: Old and new risk factors for upper extremity deep venous thrombosis. JTH 2005; 3: 2471-8.
18. Mino JS, Gutnick JR, Monteiro R, Anzlovar N, Siperstein AE: Line-associated thrombosis as the major cause of hospital-acquired deep vein thromboses: an analysis from National Surgical Quality Improvement Program data and a call to reassess prophylaxis strategies. Am J Surg 2014; 208: 45-9.
19. Kucher N: Clinical practice. Deep-vein thrombosis of the upper extremities. N Engl J Med 2011; 364: 861-9.
20. Engelberger RP, Kucher N: Management of deep vein thrombosis of the upper extremity. Circulation 2012; 126: 768-73.
21. van Es N, Bleker SM, di Nisio M, et al.: A clinical decision rule and D-dimer test - ing to rule out upper extremity deep vein thrombosis in high-risk patients. Thromb Res 2016; 148: 59-62.
22. Constans J, Salmi LR, Sevestre-Pietri MA, et al.: A clinical prediction score for upper extremity deep venous thrombosis. Thromb Haemost 2008; 99: 202-7.
23. van Es N, van der Hulle T, Buller HR, et al.: Is stand-alone D-dimer testing safe to rule out acute pulmonary embolism? JTH 2017 (Epub ahead of print).
24. El Tabei L, Holtz G, Schurer-Maly C, Abholz HH: Accuracy in diagnosing deep and pelvic vein thrombosis in primary care: an analysis of 395 cases seen by 58 primary care physicians. Dtsch Arztebl Int 2012; 109: 761-6.
25. Di Nisio M, van Sluis GL, Bossuyt PM, Buller HR, Porreca E, Rutjes AW: Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review. JTH 2010; 8: 684-92.
26. AWMF: S2k-Diagnostik und Therapie der Venenthrombose und der Lungen - embolie. www.awmf.org/leitlinien/detail/ll/003-001.html (last accessed on 25 December 2016).
27. van den Houten MM, van Grinsven R, Pouwels S, Yo LS, van Sambeek MR, Teijink JA: Treatment of upper-extremity outflow thrombosis. Phlebology 2016; 31: 28-33.
28. Schlitt A, Jambor C, Spannagl M, Gogarten W, Schilling T, Zwissler B: The peri operative management of treatment with anticoagulants and platelet aggregation inhibitors. Dtsch Arztebl Int 2013; 110: 525-32.
29. Kearon C, Akl EA, Comerota AJ, et al.: Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141: e419S-94S.
30. Lin PH, Zhou W, Dardik A, et al.: Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg 2006; 192: 782-8.
31. Cynamon J, Stein EG, Dym RJ, Jagust MB, Binkert CA, Baum RA: A new method for aggressive management of deep vein thrombosis: retrospective study of the power pulse technique. JVIR 2006; 17: 1043-9.
32. Munoz FJ, Mismetti P, Poggio R, et al.: Clinical outcome of patients with upperextremity deep vein thrombosis: results from the RIETE Registry. Chest 2008; 133: 143-8.
33. Lee AY, Levine MN, Baker RI, et al.: Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 146-53.
34. Lee AY, Bauersachs R, Janas MS, et al.: CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients. BMC Cancer 2013; 13: 284.
35. Lee AY, Kamphuisen PW, Meyer G, et al.: Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial. JAMA 2015; 314: 677-86.
36. Enden T, Haig Y, Klow NE, et al.: Long-term outcome after additional catheterdirected thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 2012; 379: 31-8.
37. Vedantham S: Interventions for deep vein thrombosis: reemergence of a promising therapy. Am J Med 2008; 121: 28-39.
38. O'Sullivan GJ, Lohan DG, Gough N, Cronin CG, Kee ST: Pharmacomechanical thrombectomy of acute deep vein thrombosis with the Trellis-8 isolated thrombolysis catheter. JVIR 2007; 18: 715-24.
39. Verso M, Agnelli G, Bertoglio S, et al.: Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo- controlled, randomized study in cancer patients. J Clin Oncol 2005; 23: 4057-62.
40. Monreal M, Alastrue A, Rull M, et al.: Upper extremity deep venous thrombosis in cancer patients with venous access devices-prophylaxis with a low molecular weight heparin (Fragmin). JTH 1996; 75: 251-3.